Format

Send to

Choose Destination
Int J Chron Obstruct Pulmon Dis. 2012;7:109-17. doi: 10.2147/COPD.S28677. Epub 2012 May 2.

Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients.

Author information

1
Department of Respiratory Medicine, Toneyama National Hospital, Osaka, Japan.

Abstract

BACKGROUND:

Tiotropium partially relieves exertional dyspnea and reduces the risk of congestive heart failure in chronic obstructive pulmonary disease (COPD) patients. However, its effect on the sympathetic activation response to exercise is unknown.

AIMS:

This study aimed to determine whether tiotropium use results in a sustained reduction in sympathetic activation during exercise.

METHODS:

We conducted a 12-week, open-label (treatments: tiotropium 18 μg or oxitropium 0.2 mg × 3 mg), crossover study in 17 COPD patients. Treatment order was randomized across subjects. The subjects underwent a pulmonary function test and two modes of cardiopulmonary exercise (constant work rate and incremental exercise) testing using a cycle ergometer, with measurement of arterial catecholamines after each treatment period.

RESULTS:

Forced expiratory volume in 1 second and forced vital capacity were significantly larger in the tiotropium treatment group. In constant exercise testing, exercise endurance time was longer, with improvement in dyspnea during exercise and reduction in dynamic hyperinflation in the tiotropium treatment group. Similarly, in incremental exercise testing, exercise time, carbon dioxide production, and minute ventilation at peak exercise were significantly higher in the tiotropium treatment group. Plasma norepinephrine concentrations and dyspnea intensity were also lower during submaximal isotime exercise and throughout the incremental workload exercise in the tiotropium treatment group.

CONCLUSION:

Tiotropium suppressed the increase of sympathetic activation during exercise at the end of the 6-week treatment, as compared with the effect of oxipropium. This effect might be attributed to improvement in lung function and exercise capacity and reduction in exertional dyspnea, which were associated with decreases in respiratory frequency and heart rate and reduced progression of arterial acidosis.

KEYWORDS:

anticholinergics; chronic obstructive pulmonary disease (COPD); exercise testing; sympathetic activation

PMID:
22615527
PMCID:
PMC3355834
DOI:
10.2147/COPD.S28677
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center